
OUR FOCUS
Fueling The Advancement of Healthcare Technology
With new technologies transforming early detection and making prognosis/disease monitoring a critical element of patient care, the Diagnostics and Tools sector is making great advances from research to clinical, elevating the category as a trusted outsourcing partner for Biopharma.
Our Diagnostics and Tools team partners with established and emerging companies as a trusted advisor across capital formation and M&A strategy.
Recent transactions

$70 Million
Exclusive Financial Advisor
Series B Financing and Strategic Collaboration with Quest Diagnostics
November 2023

$350 Million
Joint Bookrunner
Follow-On
May 2023

$117 Million
Joint Bookrunner
Follow-On
January 2023

$400 MILLION
Joint Bookrunner
Follow-On
November 2022
Featured Insights

Podcasts
April 2025
Head of U.S. Public Affairs and Patient Advocacy, Oncology with Sanofi, Elizabeth Franklin, PhD, MSW

Featured Research
April 2025
Tariff Risks Underappreciated: Key Considerations and What Companies are Saying

Articles
March 2025